SAN FRANCISCO, Nov. 9, 2010 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc., a leader in innovative biologics, announced today that Julia P. Gregory, president and chief executive officer, and Dr. Michael Kavanaugh, M.D., senior vice president and head of research and development, will be presenting at the Lazard Capital Markets 7th Annual Healthcare Conference at the St. Regis Hotel in New York, New York. Their presentation will take place on Tuesday, November 16, 2010 at 9:25 am Eastern Standard Time in the Watteau room. Ms. Gregory and Dr. Kavanaugh, M.D. will present an overview of FivePrime, discuss the company’s clinical and preclinical development programs and its recent collaboration with GlaxoSmithKline. A live webcast will also be available, which can be accessed 90 days following the conference by visiting www.wsw.com/webcast/lz8/five/.
